Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4895]

Immune cell gives possible explanation for sex differences in pancreatic cancer

Immune cell gives possible explanation for sex differences in pancreatic cancer

Nirogacestat treatment improves PFS and objective response rate for desmoid tumours

Nirogacestat treatment improves PFS and objective response rate for desmoid tumours

Lighting up tumours could help surgeons remove them more precisely

Lighting up tumours could help surgeons remove them more precisely

Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests

Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests

EAU 2023: Delaying treatment for localised prostate cancer does not increase mortality risk, trial shows

EAU 2023: Delaying treatment for localised prostate cancer does not increase mortality risk, trial shows

EAU 2023: Male or female urologist? Depends how much it hurts, research shows

EAU 2023: Male or female urologist? Depends how much it hurts, research shows

EAU 2023: Urine gene test can predict bladder cancer years before diagnosis

EAU 2023: Urine gene test can predict bladder cancer years before diagnosis

Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity mediating PD-L1 high CD11b+ cells elimination in HCC

Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity...

More proof that too many medications leads to adversity for older cancer patients

More proof that too many medications leads to adversity for older cancer patients

Alternative bladder cancer treatment emerges amid worldwide shortage of standard of care BCG

Alternative bladder cancer treatment emerges amid worldwide shortage of standard of care BCG

More from ecancer